Cambridge Cognition Overview
- Year Founded
-
1984
- Status
-
Public
- Employees
-
91
- Stock Symbol
-
COG
- Investments
-
5
- Share Price
-
$0.38
- (As of Friday Closing)
Cambridge Cognition General Information
Description
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
Contact Information
Website
www.cambridgecognition.comCorporate Office
- Tunbridge Court, Tunbridge Lane
- Bottisham
- Cambridge CB25 9TU
- England, United Kingdom
Corporate Office
- Tunbridge Court, Tunbridge Lane
- Bottisham
- Cambridge CB25 9TU
- England, United Kingdom
Cambridge Cognition Timeline
Cambridge Cognition Stock Performance
As of 13-Nov-2026, Cambridge Cognition’s stock price is $0.38. Its current market cap is $20.7M with 54M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.38 | $0.39 | $0.35 - $0.61 | $20.7M | 54M | 39.1K | -$0.04 |
Cambridge Cognition Financials Summary
As of 30-Jun-2026, Cambridge Cognition has a trailing 12-month revenue of $13.6M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 23,195 | 18,975 | 18,344 | 20,516 |
| Revenue | 13,590 | 12,382 | 13,214 | 16,800 |
| EBITDA | (682) | (877) | (719) | (3,308) |
| Net Income | (1,884) | (2,206) | (2,281) | (4,361) |
| Total Assets | 14,993 | 15,194 | 16,349 | 18,125 |
| Total Debt | 317 | 1,176 | 2,394 | 3,264 |
Cambridge Cognition Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cambridge Cognition Comparisons
Industry
Financing
Details
Cambridge Cognition Competitors (7)
One of Cambridge Cognition’s 7 competitors is Savonix, a Formerly VC-backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Savonix | Formerly VC-backed | San Francisco, CA | ||||
| CNS Vital Signs | Corporation | Morrisville, NC | ||||
| Signant Health | Private Equity-Backed | Blue Bell, PA | ||||
| BrainCheck | Venture Capital-Backed | Austin, TX | ||||
| Twill (Other Healthcare Technology Systems) | Formerly VC-backed | New York, NY |
Cambridge Cognition Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cambridge Cognition Patents
Cambridge Cognition Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4470018-A1 | System and method for assessing neurological function | Pending | 24-Jan-2022 | ||
| GB-202200859-D0 | System and method for assessing neurological function | Inactive | 24-Jan-2022 | ||
| GB-2614907-A | System and method for assessing neurological function | Inactive | 24-Jan-2022 | ||
| US-20250160729-A1 | System and method for assessing neurological function | Pending | 24-Jan-2022 | ||
| WO-2023139393-A1 | System and method for assessing neurological function | Inactive | 24-Jan-2022 | A61B5/4088 |
Cambridge Cognition Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cambridge Cognition Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Cambridge Cognition Investments & Acquisitions (5)
Cambridge Cognition’s most recent deal was a Merger/Acquisition with WinterLight Labs for . The deal was made on 10-Jan-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WinterLight Labs | 10-Jan-2023 | Merger/Acquisition | Other Healthcare Technology Systems | ||
| Clinpal | 12-Oct-2022 | Merger/Acquisition | Business/Productivity Software | ||
| Cantab Corporate Health | 31-May-2017 | Merger/Acquisition | Other Healthcare Services | ||
| Cognition Kit (Joint venture) | 21-Mar-2016 | Joint Venture | Other Healthcare Technology Systems | ||
| Cantab Corporate Health | 09-Sep-2015 | Joint Venture | Other Healthcare Services |
Cambridge Cognition ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Cambridge Cognition Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| WinterLight Labs | Toronto, Canada | 2015 |
Cambridge Cognition FAQs
-
When was Cambridge Cognition founded?
Cambridge Cognition was founded in 1984.
-
Where is Cambridge Cognition headquartered?
Cambridge Cognition is headquartered in Cambridge, United Kingdom.
-
What is the size of Cambridge Cognition?
Cambridge Cognition has 91 total employees.
-
What industry is Cambridge Cognition in?
Cambridge Cognition’s primary industry is Outcome Management (Healthcare).
-
Is Cambridge Cognition a private or public company?
Cambridge Cognition is a Public company.
-
What is Cambridge Cognition’s stock symbol?
The ticker symbol for Cambridge Cognition is COG.
-
What is the current stock price of Cambridge Cognition?
As of 13-Nov-2026 the stock price of Cambridge Cognition is $0.38.
-
What is the current market cap of Cambridge Cognition?
The current market capitalization of Cambridge Cognition is $20.7M.
-
What is Cambridge Cognition’s current revenue?
The trailing twelve month revenue for Cambridge Cognition is $13.6M.
-
Who are Cambridge Cognition’s competitors?
Savonix, CNS Vital Signs, Signant Health, BrainCheck, and Twill (Other Healthcare Technology Systems) are some of the 7 competitors of Cambridge Cognition.
-
What is Cambridge Cognition’s annual earnings per share (EPS)?
Cambridge Cognition’s EPS for 12 months was -$0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
